Publication Type Review
Authors Berti V, Osorio R, Mosconi L, Li Y, De Santi S, de Leon M
Journal Neurodegener Dis
Volume 7
Issue 1-3
Pagination 131-5
Date Published 03/03/2010
ISSN 1660-2862
Keywords Alzheimer Disease, Positron-Emission Tomography
Abstract Preclinical diagnosis of Alzheimer's disease (AD) is one of the major challenges for the prevention of AD. AD biomarkers are needed not only to reveal preclinical pathologic changes, but also to monitor progression and therapeutics. PET neuroimaging can reliably assess aspects of the molecular biology and neuropathology of AD. The aim of this article is to review the use of FDG-PET and amyloid PET imaging in the early detection of AD.
DOI 10.1159/000289222
PubMed ID 20197691
PubMed Central ID PMC3214828
Back to Top